Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 27 (LRRC27) is a protein encoded by the *LRRC27* gene located on chromosome 10q26.3 in humans, with notable transcript and protein expression in the brain and testis[1][2][3]. The protein is about 530 amino acids, features 5 leucine-rich repeat regions, and is predicted to be involved in actin binding, cytoskeletal, and cardiac muscle cell functions[1][2][3][6]. While its biological function is not fully defined, LRRC27 is implicated in disease processes such as preeclampsia (through platelet expression), primary open-angle glaucoma (through an associated SNP), and as an epigenetic biomarker for metabolic interventions[1][2][3]. There is no current evidence that LRRC27 is a direct therapeutic target, nor are there drugs known to modulate its function specifically. Its classification falls under "Other" as a leucine-rich repeat protein without established receptor, transporter, enzyme, or signaling protein functions[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 27 (LRRC27).